Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 8:10:1331206.
doi: 10.3389/fcvm.2023.1331206. eCollection 2023.

Optimizing percutaneous pulmonary valve implantation with patient-specific 3D-printed pulmonary artery models and hemodynamic assessment

Affiliations

Optimizing percutaneous pulmonary valve implantation with patient-specific 3D-printed pulmonary artery models and hemodynamic assessment

Ender Odemis et al. Front Cardiovasc Med. .

Abstract

Background: Percutaneous pulmonary valve implantation (PPVI) has emerged as a less invasive alternative for treating severe pulmonary regurgitation after tetralogy of Fallot (TOF) repair in patients with a native right ventricular outflow tract (RVOT). However, the success of PPVI depends on precise patient-specific valve sizing, the avoidance of oversizing complications, and optimal valve performance. In recent years, innovative adaptations of commercially available cardiovascular mock loops have been used to test conduits in the pulmonary position. These models are instrumental in facilitating accurate pulmonic valve sizing, mitigating the risk of oversizing, and providing insight into the valve performance before implantation. This study explored the utilization of custom-modified mock loops to implant patient-specific 3D-printed pulmonary artery geometries, thereby advancing PPVI planning and execution.

Material and methods: Patient-specific 3D-printed pulmonary artery geometries of five patients who underwent PPVI using Pulsta transcatheter heart valve (THV) ® were tested in a modified ViVitro pulse duplicator system®. Various valve sizes were subjected to 10 cycles of testing at different cardiac output levels. The transpulmonary systolic and regurgitation fractions of the valves were also recorded and compared.

Results: A total of 39 experiments were conducted using five different patient geometries and several different valve sizes (26, 28, 30, and 32 mm) at 3, 4, and 5 L/min cardiac output at heart rates of 70 beats per minute (bpm) and 60/40 systolic/diastolic ratios. The pressure gradients and regurgitation fractions of the tested valve sizes in the models were found to be similar to the pressure gradients and regurgitation fractions of valves used in real procedures. However, in two patients, different valve sizes showed better hemodynamic values than the actual implanted valves.

Discussion: The use of 3D printing technology, electromagnetic flow meters, and the custom-modified ViVitro pulse duplicator system® in conjunction with patient-specific pulmonary artery models has enabled a comprehensive assessment of percutaneous pulmonic valve implantation performance. This approach allows for accurate valve sizing, minimization of oversizing risks, and valuable insights into hemodynamic behavior before implantation. The data obtained from this experimental setup will contribute to advancing PPVI procedures and offer potential benefits in improving patient outcomes and safety.

Keywords: 3D models; Pulsta; ViVitro; ViVitro percutaneous pulmonary valve implantation; hemodynamic; in vitro hemodynamic; percutaneous pulmonary valve implantation; tetralogy of fallot.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Pulmonary artery segmentation of the patients. (B) STL model generation. (C) fluoroscopic evaluation of the valve placement. (D) Pulsta Valve 26 mm implantation on the 3D printed model. (E) Placement on ViVitro Pulse Duplicator system with in-house made mounts.
Figure 2
Figure 2
STL views of the patients.
Figure 3
Figure 3
Pulsatile flow experiments. Measurement locations and 3D patient model connection ports are illustrated. Patient models were introduced in the mock-up single-ventricle circuit featuring patient-specific 3D printed mounts with Luer lock ports for pressure measurements. The pulse duplicator sets the mock-up system flow rate by adjusting stroke and stroke volume. Pulsatile pressure measurements were acquired from the MPA root and left/right PAs. The pulse duplicator's electromagnetic flowmeter (EM) was kept at its original place under the PA root. Another ultrasonic clamp on the flow meter was also used for the calibration of the EM flow meter. Fixtures were adjusted to avoid buckling of the patient models due to tensions on the silicone tubes.
Figure 4
Figure 4
Pressure waveform of patient 2 at 3 L/min for all valve sizes tested are shown (left). Flowmeter measurements of the same test conditions are given (right). The highest gradient observed was with the 30 mm valve, which also showed the largest regurgitation by percentage.

Similar articles

Cited by

References

    1. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of fallot. N Engl J Med. (1993) 329(9):593–9. 10.1056/NEJM199308263290901 - DOI - PubMed
    1. Nollert G, Fischlein T, Bouterwek S, Böhmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. (1997) 30(5):1374–83. 10.1016/s0735-1097(97)00318-5 - DOI - PubMed
    1. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. (1995) 92(2):231–7. 10.1161/01.cir.92.2.231 - DOI - PubMed
    1. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of fallot: a multicentre study. Lancet. (2000) 356(9234):975–81. 10.1016/S0140-6736(00)02714-8 - DOI - PubMed
    1. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. Task force on the management of grown-up congenital heart disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. (2010) 31(23):2915–57. 10.1093/eurheartj/ehq249 - DOI - PubMed

LinkOut - more resources